title: LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.
abstract: Recent studies reported that long non-coding RNA (lncRNA) might play critical roles in regulating chemo-resistant of multiple types of cancer. This study aimed to investigate whether long non-coding RNA CCAT1 was involved in Paclitaxel resistance in nasopharyngeal carcinoma (NPC). qRT-PCR was used for testing the expression of CCAT1, miR-181a and CPEB2 in tumor tissues and NPC cancers. NPC cells were transfected with siRNAs to suppress the mRNA level of CCAT1 in NPC cells. MTT assays and flow cytometry analysis were used to assess the sensitivity of paclitaxel in NPC cells. Luciferase reporter assays were used to examine the interaction of CCAT1 or CPEB2 to miR-181a. Our findings revealed that the upregulated CCAT1 results in significantly enhancing paclitaxel resistance in nasopharyngeal cancer cells. Bioinformatics analysis and luciferase reporter assay indicated that the upregulated CCAT1 sponges miR-181a in NPC cells. Furthermore, RNA immuno-precipitation assays showed that miR-181a could directly bind to CCAT1 mRNA in NPC cells. We restored miR-181a in NPC cells, and found restoration of miR-181a re-sensitized the NPC cells to paclitaxel in vitro. In addition, our results also showed that miR-181a was a modulator of paclitaxel sensitivity due to its regulative effect on cell apoptosis via targeting CPEB2 in NPC cells. Taken together, lncRNA CCAT1 regulates the sensitivity of paclitaxel in NPC cells via miR-181a/CPEB2 axis.
authors.affiliation: a The E.N.T Department , The First affiliated Hospital of Zhengzhou University , Zhengzhou , Henan , China.
authors.forename: Qiaosu
authors.initials: Q
authors.lastname: Wang
authors.affiliation: a The E.N.T Department , The First affiliated Hospital of Zhengzhou University , Zhengzhou , Henan , China.
authors.forename: Wenjing
authors.initials: W
authors.lastname: Zhang
authors.affiliation: a The E.N.T Department , The First affiliated Hospital of Zhengzhou University , Zhengzhou , Henan , China.
authors.forename: Shaojuan
authors.initials: S
authors.lastname: Hao
mesh_terms: D001483:Base Sequence; D002277:Carcinoma; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D055785:Gene Knockdown Techniques; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000235:genetics* / Q000473:pathology; D017239:Paclitaxel / Q000494:pharmacology*; D062085:RNA, Long Noncoding / Q000235:genetics / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: C579842:CCAT1 long noncoding RNA, human; C554938:CPEB2 protein, human; C000608460:MIRN-181 microRNA, human; D035683:MicroRNAs; D062085:RNA, Long Noncoding; D016601:RNA-Binding Proteins; D017239:Paclitaxel
keywords: CCAT1; CPEB2; Long non-coding RNA; Nasopharyngeal carcinoma; miR-181a